# Genmab Stock Surges to Record High as Cancer Drug Slashes Risk of Death by 50%

> **Newsylist Open Intelligence Dossier** · First detected: 2026-10-29 04:29 UTC · Category: Business · Sources: 7 · Current Velocity: 4.63

## Intelligence Brief
"Genmab Stock Surges to Record High as Cancer Drug Slashes Risk of Death by 50%" developed substantial multi-source reporting across the Business sector, tracked across 5 distinct newsrooms by Newsylist.


Key reporting was led by WSJ, BioSpace, Yahoo Finance and Fierce Biotech. Coverage velocity and cross-outlet momentum were measured using Newsylist open coverage telemetry.


Synthesized from multi-source international reporting and live coverage telemetry under Newsylist open intelligence methodology.

## Verified Facts & Key Claims
### What drove coverage for Genmab Stock Surges to Record High as Cancer Drug Slashes Risk of Death by ?
Coverage spiked when 5 independent newsrooms published 5 verified reports during this coverage cycle.

### How did Newsylist track this trend?
Newsylist monitored article arrival rates, source diversity, and cross-outlet validation in real time.

## Key People, Organizations & Locations
Stock, Death, Record, Cancer, Surges, Risk, Drug, High, Slashes, Genmab

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| Seeking Alpha | Genmab stock rises on Phase 3 cancer trial data (GMAB:NASDAQ) | 2026-10-28 20:19 | [Source Link](https://news.google.com/rss/articles/CBMiigFBVV95cUxPV3o3V0xZZWhpdmxCdFRhS01NR29LU09EdjFJUHZleUlKT0JncHhYVHB3aUhDS1MxOEdjN2hUYkFYTlRiYVdxWmlZZ1NqV2QyY3J4UzRSY2pxM29WWXlicXZSZzd2THd6WTVDME9Ya1Ntb0stUVBpQlQ1bmlFYWFnSy14aUtNWXJLTUE?oc=5) |
| MedWatch | Genmab soars as key cancer drug succeeds in late-stage trial | 2026-10-28 20:19 | [Source Link](https://news.google.com/rss/articles/CBMib0FVX3lxTFBManVSQ1dMTlJvNWx6Um9iemd2VDAzYUhuWHNsNkFENHVqLVZDbnBkeGs4RDJUSjJXOUp4cHVEeHFWUHJuWlBtLTVzQW5uSGc3ckVTOGVmOGpHVC1fOHNjNlZuODdwNWFiMnNfNFNSWQ?oc=5) |
| WSJ | Genmab Shares Soar on Success in Head and Neck Cancer | 2026-10-28 20:19 | [Source Link](https://news.google.com/rss/articles/CBMi7wFBVV95cUxNUzVNa2ZhclJyR3JtTVVIakxCOEx6eUNuc3FLR3ViZTRmNk1YQ1d1V1FQeWkxYmlRNWw2Ul9WSi1uNlBSTndweWpaVnJEMmVBMThOLVk5U3FLaHJMZzMyaVZIeWhWcHN1a3l4T1hsTl9mVXFiN1dkR0o5WXFmVFVyMDlOWGdyaGdwOFVHUi15UDRET0t0empnMUp3MmFSVExmZjZxQlV1WFlVSDRma0s5UzV0MzA4b1RFdnA3aF9IRlN4UGxBbmFtOHk0SGJJSTlCUnRDaWFvc1JfZWdUWENUbDJMX1FORHJaVFF0bVFVNA?oc=5) |
| BioSpace | Genmab’s cancer bispecific delivers early survival win in ‘exceedingly positive’ Phase 3 readout | 2026-10-28 20:19 | [Source Link](https://news.google.com/rss/articles/CBMi0AFBVV95cUxQMThiQ01VU2F5OFNFUUhOY2JqS21hVFJmSlJGbktWYjNNVEJKcDRGNGRZaVZsUF9nYkZndW1nSmdfeVlNZ0NwZUdxVzJmQk9JUTQ3cW9vY0hWYlp3MGkxSjdfaWZuMllYWV9lUUtWbDhWN3o2TGVwejd3VElWMmVqTndMWmJ0aGFiY0dWYnV0LVYtR0hCQVpGTlRMR3ZTa2VUOGx0bE5pU0Ezc2Fsc3RFTjZ2Z3hwU3JxMlc3bmRTNlVLSHR1d3hHNDE4SjIyNENM?oc=5) |
| Yahoo Finance | GMAB Stock Hits All-Time High After Genmab’s Cancer Drug Trial Meets Primary Goals | 2026-10-28 20:19 | [Source Link](https://news.google.com/rss/articles/CBMilAFBVV95cUxQd2NJX0o3eWt6TG9zXzA4bWNKXzVyNWhqUDl6NVVtNWlvamdUR3BDQXhJU05nYW1hQW96YmZ6ZF9ubkR6NWV4RkVzcUQ4NGdXZHBmclFiUDI4d1RPN0xzQ3BLZnNZb2E0TTBnbWNPZi1iZkVkaWNUSWV4ejR0UGEtajhfQTBWXzFwMV9UYzMybnZYdVl0?oc=5) |
| Fierce Biotech | Genmab's $8B Merus bet delivers as bispecific combo halves risk of death in phase 3 | 2026-10-28 20:19 | [Source Link](https://news.google.com/rss/articles/CBMipAFBVV95cUxOaGZDMDVVV3FNSFZqeEVzM1JaUHZfRHpHcDBqS1BFZEoxUHZfcTR1U0c0ZmFOOWczNnpKcVNWaEZWV2lBNkFrVmFXdXczN3gyRV8xT19YdmpmM0tYMTFhR0RaRlN4d2g3UVhJSVR4X3J3Ni0zUmJadE51X2M3c0duSzVpdm83VHJjMjdmMV93bkdLa2VNREFPazdNQ0lyN0pRZTdBbg?oc=5) |
| Barron's | Genmab Stock Surges to Record High as Cancer Drug Slashes Risk of Death by 50% | 2026-10-28 20:19 | [Source Link](https://news.google.com/rss/articles/CBMihAFBVV95cUxPYlRvUDRDOFJwb2dGZWtNNXRXWWN0ZGV3XzNUWGk0ckR4bjV1ZmQ1c0FLZHhUYVFXQmtQNndzR3lHQkRUNWo3WC0yNWFWZjBjNFUzc0t6ZVh4ZDNEbGZZVHF3eFV2dUlhX19BOFZ3aWhhamFYYUc5bFpOYVhpWGhfVkdDMWs?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-10-29/genmab-stock-surges-to-record-high-as-cancer-drug-slashes-risk-of-death-by-50*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*